Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,399,752
+$1,399,752 QoQ
Shares Held
29,198
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#441
of 1,348 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$39,627,204
CallShares
826,600
PutValue
$133,244,436
PutShares
2,779,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. NVO ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in NVO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,244,436 | 2,779,400 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $39,627,204 | 826,600 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $1,399,752 | 29,198 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,651,750 | 181,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $58,807,350 | 1,600,200 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $16,195,104 | 318,300 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $14,628,000 | 287,500 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $10,509,806 | 189,400 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $82,002,662 | 1,188,100 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $10,665,984 | 153,600 | Call | Defined | 2025-07-21 | |
| 2024-12-31 | $68,816,000 | 800,000 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $16,945,940 | 197,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $17,550,918 | 147,400 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $137,152,299 | 960,854 | Shares | Defined | 2024-09-16 | |
| 2024-06-30 | $2,369,484 | 16,600 | Call | Defined | 2024-09-16 | |
| 2024-03-31 | $14,971,440 | 116,600 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $10,345,000 | 100,000 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $80,027,200 | 880,000 | Put | Defined | 2023-11-14 | |
| 2023-06-30 | $10,842 | 67 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $2,927,266 | 26,270 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $64,942,040 | 584,800 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||